Differences between revisions 4 and 5
Revision 4 as of 2019-05-02 14:07:09
Size: 1046
Editor: 3678E
Comment:
Revision 5 as of 2019-05-02 14:07:23
Size: 1046
Editor: 3678E
Comment:
Deletions are marked like this. Additions are marked like this.
Line 4: Line 4:
__Atheroscscleeosis __ __Atheroscsclerosis __

Itt írjon a(z) lysophosphatidic_acid-ról/ről

Atheroscsclerosis

The effects of lysophosphatidic acid on the vascular system with a in depth look at atherosclerosis. Atherosclerosis is the narrowing of the arteries due to the disposition of plaque. Atherosclerosis is a slowly progressing, multifocal, chronic arterial disease that is characterized by inflammatory and regenerative processes, which lead to matrix remodelling and large lipid deposits. The retention of low-density lipoproteins (LDL) and activation of endothelial cells initiate atherosclerotic lesion formation in the inner layer (intima) of medium and large-sized arteries, such as coronary arteries and cerebral arteries, predominantly at predilection sites, where the laminar blood flow is disturbed (Libby et al., 2011; Weber and Noels, 2011) As cardiac disease is a leading cause of death throughout the Western world, research into this area may prevent the influx in cardiovascular disease in further years to come.

lysophosphatidic_acid (last edited 2019-05-21 15:19:40 by IstvanToth)